Circio Holding ASA — Director's Dealing 2026

Jan 29, 2026

Notification of transactions by primary insiders and their closely associated persons

1	Details of the Primary Insider/Close Associate
a)	Name	Biopharma Drug Licensing Group, SL
2	Reason for the notification
a)	Position/status	Closely associated to CFO, Lubor Gaal
b)	Initial	Initial notification
	notification/Amendment
3	Details of issuer
a)	Name	Circio Holding ASA
b)	LEI	5967007LIEEXZXFYNS31
4		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii)
		each date; and (iv) each place where transactions have been conducted
a)	Description of the financial	Subscription rights (ISIN NO0013711515) to shares in Circio Holding ASA (ISIN
	instrument, type of	NO0013033795)
	instrument
	Identification code
b)	Nature of the transaction	Exercise of subscription rights
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 1,0	65,164
d)	Aggregated information	65,164 subscription rights for a price of NOK 65,164
	—Aggregated volume
	—Price
e)	Date of the transaction	2026-01-28
f)	Place of the transaction	XOFF – Outside of trading venue